Abdallah BM, Boissy P, Tan Q, Dahlgaard J, Traustadottir GA, Kupisiewicz K, Laborda J, Delaisse J-M, Kassem M (2007) dlk1/FA1 regulates the function of human bone marrow mesenchymal stem cells by modulating gene expression of pro-inflammatory cytokines and immune response-related factors. J Biol Chem 282:7339–7351

Article  PubMed  Google Scholar 

Al-Kuraishy HM, Al-Fakhrany OM, Elekhnawy E, Al-Gareeb AI, Alorabi M, De Waard M, Albogami SM, Batiha GE-S (2022a) Traditional herbs against COVID-19: back to old weapons to combat the new pandemic. Eur J Med Res 27:1–11

Article  Google Scholar 

Al-Kuraishy HM, Al-Gareeb AI, Al-Maiahy TJ, Alexiou A, Mukerjee N, Batiha GE-S (2022b) An insight into the placental growth factor (PlGf)/angii axis in COVID-19: a detrimental intersection. Biotechnol Gen Eng Rev, 1–20

Al-kuraishy HM, Al-Gareeb AI, Alkhuriji AF, Al-Megrin WAI, Elekhnawy E, Negm WA, De Waard M, Batiha GE-S (2022a) Investigation of the impact of rosuvastatin and telmisartan in doxorubicin-induced acute cardiotoxicity. Biomed Pharmacother 154:113673

Article  Google Scholar 

Al-Kuraishy HM, Al-Gareeb AI, Almulaiky YQ, Cruz-Martins N, Batiha GE-S (2021a) Role of leukotriene pathway and montelukast in pulmonary and extrapulmonary manifestations of COVID-19: the enigmatic entity. Eur J Pharmacol 904:174196

Article  PubMed  PubMed Central  Google Scholar 

Al-Kuraishy HM, Al-Gareeb AI, Alzahrani KJ, Alexiou A, Batiha GE-S (2021b) Niclosamide for COVID-19: bridging the gap. Mol Biol Rep 48:8195–8202

Article  PubMed  PubMed Central  Google Scholar 

Al-kuraishy HM, Al-Gareeb AI, Elekhnawy E, Batiha GE-S (2022b) Dipyridamole and adenosinergic pathway in COVID-19: a juice or holy grail. Egypt J Med Human Gen 23:1–6

Google Scholar 

Al-Kuraishy HM, Al-Gareeb AI, Mostafa-Hedeab G, Dubey R, Prabhakar PK, Batiha G (2022e) COVID-19 and diabetes: will novel drugs for diabetes help in COVID-19? Curr Mol Pharmacol

Al-Kuraishy HM, Al-Gareeb AI, Mostafa-Hedeab G, Kasozi KI, Zirintunda G, Aslam A, Allahyani M, Welburn SC, Batiha GE-S (2021c) Effects of β-blockers on the sympathetic and cytokines storms in COVID-19. Front Immunol, 12

Al-Kuraishy HM, Al-Gareeb AI, Negm WA, Alexiou A, Batiha GE-S (2022f) Ursolic acid and SARS-CoV-2 infection: a new horizon and perspective. Inflammopharmacology, 1–9

Al-Kuraishy HM, Al-Gareeb AI, Qusti S, Alshammari EM, Gyebi GA, Batiha GE-S (2021d) COVID-19-induced dysautonomia: a menace of sympathetic storm. ASN neuro, 13 17590914211057635

Al-Kuraishy HM, Al-Gareeb AI, Welson NN, Batiha GE-S (2022g) Trimetazidine and COVID-19-induced acute cardiac injury: a missed key. Intl J Clin Pharm, 1–2

Al-Thomali AW, Al-Kuraishy HM, Al-Gareeb AI, Al-buhadiliy AK, De Waard M, Sabatier J-M, Khan Khalil AA, Saad HM, Batiha GE-S (2022) Role of neuropilin 1 in COVID-19 patients with acute ischemic stroke. Biomedicines 10:2032

Article  PubMed  PubMed Central  Google Scholar 

Alexandris N, Lagoumintzis G, Chasapis CT, Leonidas DD, Papadopoulos GE, Tzartos SJ, Tsatsakis A, Eliopoulos E, Poulas K, Farsalinos K (2021) Nicotinic cholinergic system and COVID-19: in silico evaluation of nicotinic acetylcholine receptor agonists as potential therapeutic interventions. Toxicol Rep 8:73–83

Article  PubMed  Google Scholar 

Alomair BM, Al-Kuraishy HM, Al-Buhadily AK, Al-Gareeb AI, De Waard M, Elekhnawy E, Batiha GE-S (2022) Is sitagliptin effective for SARS-CoV-2 infection: false or true prophecy? Inflammopharmacology, 1–5

Attallah NG, El-Kadem AH, Negm WA, Elekhnawy E, El-Masry TA, Elmongy EI, Altwaijry N, Alanazi AS, Al-Hamoud GA, Ragab AE (2021) Promising antiviral activity of Agrimonia pilosa phytochemicals against severe acute respiratory syndrome coronavirus 2 supported with in vivo mice study. Pharmaceuticals 14:1313

Article  PubMed  PubMed Central  Google Scholar 

Babalghith AO, Al-Kuraishy HM, Al-Gareeb AI, De Waard M, Sabatier J-M, Saad HM, Batiha GE-S (2022) The potential role of growth differentiation factor 15 in COVID-19: a corollary subjective effect or not? Diagnostics 12:2051

Article  PubMed  PubMed Central  Google Scholar 

Bahloul M, Kharrat S, Makni S, Baccouche N, Ammar R, Eleuch A, Berrajah L, Chtourou A, Turki O, Chelly H (2022) Prognostic value of serum cholinesterase activity in severe SARS-CoV-2-infected patients requiring intensive care unit admission. Am J Trop Med Hyg, tpmd210934-tpmd210934

Batiha GE-S, Al-Gareeb AI, Elekhnawy E, Al-Kuraishy HM (2022) Potential role of lipoxin in the management of COVID-19: a narrative review. Inflammopharmacology, 1–9

Batiha GE-S, Gari A, Elshony N, Shaheen HM, Abubakar MB, Adeyemi SB, Al-Kuraishy HM (2021) Hypertension and its management in COVID-19 patients: the assorted view. Intl J Cardiol Cardiovasc Risk Prev 11:200121

Article  Google Scholar 

Bekdash RA (2021) The cholinergic system, the adrenergic system and the neuropathology of Alzheimer’s disease. Int J Mol Sci 22:1273

Article  PubMed  PubMed Central  Google Scholar 

Bonaventura A, Vecchié A, Dagna L, Martinod K, Dixon DL, Van Tassell BW, Dentali F, Montecucco F, Massberg S, Levi M (2021) Endothelial dysfunction and immunothrombosis as key pathogenic mechanisms in COVID-19. Nat Rev Immunol 21:319–329

Article  PubMed  PubMed Central  Google Scholar 

Calabretta E, Moraleda JM, Iacobelli M, Jara R, Vlodavsky I, O’Gorman P, Pagliuca A, Mo C, Baron RM, Aghemo A (2021) COVID-19-induced endotheliitis: emerging evidence and possible therapeutic strategies. Br J Haematol 193:43–51

Article  PubMed  PubMed Central  Google Scholar 

Courties A, Boussier J, Hadjadj J, Yatim N, Barnabei L, Péré H, Veyer D, Kernéis S, Carlier N, Pène F (2021) Regulation of the acetylcholine/α7nAChR anti-inflammatory pathway in COVID-19 patients. Sci Rep 11:1–8

Article  Google Scholar 

Cox M, Bassi C, Saunders M, Nechanitzky R, Morgado-Palacin I, Zheng C, Mak T (2020) Beyond neurotransmission: acetylcholine in immunity and inflammation. J Intern Med 287:120–133

Article  PubMed  Google Scholar 

Cox MA, Duncan GS, Lin GH, Steinberg BE, Yu LX, Brenner D, Buckler LN, Elia AJ, Wakeham AC, Nieman B (2019) Choline acetyltransferase-expressing T cells are required to control chronic viral infection. Science 363:639–644

Article  PubMed  PubMed Central  Google Scholar 

De Rosa MJ, Dionisio L, Agriello E, Bouzat C, del Carmen Esandi M (2009) Alpha 7 nicotinic acetylcholine receptor modulates lymphocyte activation. Life Sci 85:444–449

Article  PubMed  Google Scholar 

Deng Y, Guo S-L, Wei B, Gao X-C, Zhou Y-C, Li J-Q (2019) Activation of nicotinic acetylcholine α7 receptor attenuates progression of monocrotaline-induced pulmonary hypertension in rats by downregulating the NLRP3 inflammasome. Front Pharmacol 10:128

Article  PubMed  PubMed Central  Google Scholar 

Ekins S, Mathews P, Saito EK, Diaz N, Naylor D, Chung J, McMurtray AM (2017) α7-Nicotinic acetylcholine receptor inhibition by indinavir: implications for cognitive dysfunction in treated HIV disease. AIDS 31:1083–1089

Article  PubMed  Google Scholar 

Elekhnawy E, Negm WA (2022) The potential application of probiotics for the prevention and treatment of COVID-19. Egypt J Med Human Gen 23:1–9

Google Scholar 

Elekhnawy E, Negm WA, El-Sherbeni SA, Zayed A (2022) Assessment of drugs administered in the Middle East as part of the COVID-19 management protocols. Inflammopharmacology, 1–20

Farsalinos K, Niaura R, Le Houezec J, Barbouni A, Tsatsakis A, Kouretas D, Vantarakis A, Poulas K (2020) Nicotine and SARS-CoV-2: COVID-19 may be a disease of the nicotinic cholinergic system. Toxicol Rep 7:658

Article  PubMed  PubMed Central  Google Scholar 

Fujii YX, Fujigaya H, Moriwaki Y, Misawa H, Kasahara T, Grando SA, Kawashima K (2007) Enhanced serum antigen-specific IgG1 and proinflammatory cytokine production in nicotinic acetylcholine receptor α7 subunit gene knockout mice. J Neuroimmunol 189:69–74

Article  PubMed  Google Scholar 

Gavriilaki E, Anyfanti P, Gavriilaki M, Lazaridis A, Douma S, Gkaliagkousi E (2020) Endothelial dysfunction in COVID-19: lessons learned from coronaviruses. Curr Hypertens Rep 22:1–12

Article  Google Scholar 

Goller KV, Moritz J, Ziemann J, Kohler C, Becker K, Hübner N-O, C.-G. S. Group (2022) Differences in clinical presentations of omicron infections with the lineages BA. 2 and BA. 5 in Mecklenburg-Western Pomerania, Germany, between April and July 2022. Viruses, 14, 2033.

Gori S, Alcain J, Vanzulli S, Moreno Ayala MA, Candolfi M, Jancic C, Geffner J, Vermeulen M, Salamone G (2019) Acetylcholine-treated murine dendritic cells promote inflammatory lung injury. PLoS One 14:e0212911

Article  PubMed  PubMed Central  Google Scholar 

Halder N, Lal G (2021) Cholinergic system and its therapeutic importance in inflammation and autoimmunity. Front Immunol 12:660342

Article  PubMed  PubMed Central  Google Scholar 

Hampel H, Mesulam M-M, Cuello AC, Farlow MR, Giacobini E, Grossberg GT, Khachaturian AS, Vergallo A, Cavedo E, Snyder PJ (2018) The cholinergic system in the pathophysiology and treatment of Alzheimer’s disease. Brain 141:1917–1933

Article  PubMed  PubMed Central  Google Scholar 

Hattori Y, Hattori K, Machida T, Matsuda N (2022) Vascular endotheliitis associated with infections: its pathogenetic role and therapeutic implication. Biochem Pharmacol, 114909

Hernandez CP, Morrow K, Velasco C, Wyczechowska DD, Naura AS, Rodriguez PC (2013) Effects of cigarette smoke extract on primary activated T cells. Cell Immunol 282:38–43

Article  PubMed  PubMed Central  Google Scholar 

Hong GS, Zillekens A, Schneiker B, Pantelis D, de Jonge WJ, Schaefer N, Kalff JC, Wehner S (2019) Non-invasive transcutaneous auricular vagus nerve stimulation prevents postoperative ileus and endotoxemia in mice. Neurogastroenterol Motil 31:e13501

Article  PubMed  Google Scholar 

Huston JM, Ochani M, Rosas-Ballina M, Liao H, Ochani K, Pavlov VA, Gallowitsch-Puerta M, Ashok M, Czura CJ, Foxwell B (2006) Splenectomy inactivates the cholinergic antiinflammatory pathway during lethal endotoxemia and polymicrobial sepsis. J Exp Med 203:1623–1628

Article  PubMed  PubMed Central  Google Scholar 

Ikonomidis I, Marinou M, Vlastos D, Kourea K, Andreadou I, Liarakos N, Triantafyllidi H, Pavlidis G, Tsougos E, Parissis J (2017) Effects of varenicline and nicotine replacement therapy on arterial elasticity, endothelial glycocalyx and oxidative stress during a 3-month smoking cessation program. Atherosclerosis 262:123–130

Article  PubMed  Google Scholar 

Jackisch R, Förster S, Kammerer M, Rothmaier AK, Ehret A, Zentner J, Feuerstein TJ (2009) Inhibitory potency of choline esterase inhibitors on acetylcholine release and choline esterase activity in fresh specimens of human and rat neocortex. J Alzheimers Dis 16:635–647

Article  PubMed  Google Scholar 

Jiang Y, Ma H, Wang X, Wang Z, Yang Y, Li L, Feng T (2021) Protective effect of the α7 nicotinic receptor agonist PNU-282987 on dopaminergic neurons against 6-hydroxydopamine, regulating anti-neuroinflammatory and the immune balance pathways in rat. Front Aging Neurosci 12:606927

Article  PubMed  PubMed Central  Google Scholar 

Jiménez-Jiménez FJ, Alonso-Navarro H, García-Martín E, Agúndez JA (2020) Anti-inflammatory effects of amantadine and memantine: possible therapeutics for the treatment of COVID-19? J Person Med 10:217

Article  Google Scholar 

Kabata H, Artis D (2019) Neuro-immune crosstalk and allergic inflammation. J Clin Investig 129:1475–1482

Article  PubMed  PubMed Central  Google Scholar 

Kanauchi Y, Yamamoto T, Yoshida M, Zhang Y, Lee J, Hayashi S, Kadowaki M (2022) Cholinergic anti-inflammatory pathway ameliorates murine experimental Th2-type colitis by suppressing the migration of plasmacytoid dendritic cells. Sci Rep 12:1–18

Article